DK1063294T3 - DNA'er eller gener der deltager i Parkinsons sygdom - Google Patents

DNA'er eller gener der deltager i Parkinsons sygdom

Info

Publication number
DK1063294T3
DK1063294T3 DK99902859T DK99902859T DK1063294T3 DK 1063294 T3 DK1063294 T3 DK 1063294T3 DK 99902859 T DK99902859 T DK 99902859T DK 99902859 T DK99902859 T DK 99902859T DK 1063294 T3 DK1063294 T3 DK 1063294T3
Authority
DK
Denmark
Prior art keywords
disease
parkinson
dnas
genes involved
sequence
Prior art date
Application number
DK99902859T
Other languages
English (en)
Inventor
Yoshikuni Mizuno
Nobuyoshi Shimizu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1063294T3 publication Critical patent/DK1063294T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK99902859T 1998-02-09 1999-02-09 DNA'er eller gener der deltager i Parkinsons sygdom DK1063294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2753198 1998-02-09

Publications (1)

Publication Number Publication Date
DK1063294T3 true DK1063294T3 (da) 2006-05-22

Family

ID=12223704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902859T DK1063294T3 (da) 1998-02-09 1999-02-09 DNA'er eller gener der deltager i Parkinsons sygdom

Country Status (10)

Country Link
US (2) US6716621B1 (da)
EP (1) EP1063294B1 (da)
JP (1) JP4430815B2 (da)
AT (1) ATE315645T1 (da)
AU (1) AU2299999A (da)
CA (1) CA2320220C (da)
DE (2) DE1063294T1 (da)
DK (1) DK1063294T3 (da)
ES (1) ES2257029T3 (da)
WO (1) WO1999040191A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
DK1063294T3 (da) * 1998-02-09 2006-05-22 Boehringer Ingelheim Int DNA'er eller gener der deltager i Parkinsons sygdom
WO2000031253A2 (fr) 1998-11-19 2000-06-02 Aventis Pharma S.A. Mutations du gene de la parkine, compositions, methodes et utilisations
CA2872581C (fr) 1998-11-19 2018-04-10 Aventis Pharma S.A. Mutations du gene de la parkine, compositions, methodes et utilisations
EP1081225A1 (en) * 1999-08-30 2001-03-07 Biofrontera Pharmaceuticals GmbH Transgenic animal model for neurodegenerative diseases
EP1262557B1 (en) * 2000-02-24 2006-10-18 Boehringer Ingelheim International GmbH Parkin protein as ubiquitin ligase
WO2001070944A2 (de) * 2000-03-22 2001-09-27 Aventis Pharma Deutschland Gmbh Nematoden als modellorganismen zur untersuchung neurodegenerativer erkrankungen und insbesonder der parkinsonschen erkrankung, verwendungen und verfahren zum auffinden von substanzen und genen, die bei der behandlung solcher erfrankungen eingesetz werden können, sowie identifizierung eines nematodengens.
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
TW200509968A (en) * 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US20080014194A1 (en) 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
US8697082B2 (en) 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US9034337B2 (en) 2003-10-31 2015-05-19 Prothena Biosciences Limited Treatment and delay of outset of synucleinopathic and amyloidogenic disease
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
WO2005047860A2 (en) 2003-11-08 2005-05-26 Elan Pharmaceuticals, Inc. Antibodies to alpha-synuclein
CA2677231C (en) 2007-01-31 2015-11-24 Elan Pharmaceuticals, Inc. Assays for modulators of parkin activity using novel substrates
US8147833B2 (en) 2007-02-23 2012-04-03 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
PL2118300T3 (pl) 2007-02-23 2015-11-30 Prothena Biosciences Ltd Zapobieganie i leczenie synukleinopatii i amyloidozy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1063294T3 (da) * 1998-02-09 2006-05-22 Boehringer Ingelheim Int DNA'er eller gener der deltager i Parkinsons sygdom

Also Published As

Publication number Publication date
CA2320220A1 (en) 1999-08-12
EP1063294B1 (en) 2006-01-11
DE69929417T2 (de) 2006-08-03
AU2299999A (en) 1999-08-23
EP1063294A4 (en) 2002-01-16
DE1063294T1 (de) 2003-06-26
US20050003385A1 (en) 2005-01-06
JP4430815B2 (ja) 2010-03-10
ES2257029T3 (es) 2006-07-16
US6716621B1 (en) 2004-04-06
ATE315645T1 (de) 2006-02-15
WO1999040191A1 (en) 1999-08-12
EP1063294A1 (en) 2000-12-27
DE69929417D1 (de) 2006-04-06
CA2320220C (en) 2011-08-02

Similar Documents

Publication Publication Date Title
DE69929417D1 (de) Dns oder gene, die an der parkinsonschen krankheit beteiligt sind
DK1013661T3 (da) 2'-O,4'-metylen bicyklonukleosid
ATE232880T1 (de) Neue nucleotidanaloga
DE69834056D1 (de) De novo oder "universaler" sequenzierungs-array
DE69729122D1 (de) KüNSTLICHE FEHLHYBRIDISIERUNG
EP0251786A3 (en) Alkynylamino-nucleotides
IL144374A0 (en) Method of identifying cytosine methylation patterns in genomic dna samples
DE69638183D1 (de) Verwendung von nukleinsäureliganden in der durchflusszytometrie
ATE318900T1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
ATE419382T1 (de) Identifizierung von dna-polymorphismen mittels durchflusszytometrie
CY1108240T1 (el) ΑΠΟΜΟΝΩΜΕΝΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΤΑ ΟΠΟΙΑ ΕΧΟΥΝ ΕΝΑ ΜΕΙΩΜΕΝΟ ΠΕΡΙΕΧΟΜΕΝΟ ΜΟΤΙΒΩΝ 5΄CpG3΄ ΕΠΙΓΕΝΕΤΙΚΟΥ ΕΛΕΓΧΟΥ ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ
ATE551420T1 (de) Gentransfer und expression mit hoher effizienz in säugerzellen mittels eines mehrfachtransfektionsverfahrens von matrixbindungsbereichsequenzen
DE69840748D1 (de) Verfahren zur zubereitung von antisense oligonukleotiden
ATE336591T1 (de) Nachweisverfahren für kurze sequenzvarianten
DE69534855D1 (de) Enzymaktive dna moleküle
ATE309333T1 (de) Synthetische polynukleotide
CY1107335T1 (el) ΝΕΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ ΤΟΥ ΓΟΝΙΔΙΟΥ IFNα-17
ATE386819T1 (de) Verfahren zur analyse von aflp reaktionsmischungen unter verwendung von primer verlängerungstechniken
WO2000063441A3 (en) Single nucleotide polymorphisms in mitochondrial genes that segregate with alzheimer's disease
DE69815370D1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
ATE270331T1 (de) Rezeptor und dafür kodierendes nukleinsäuremolekül
NO995858L (no) Ny klasse kationiske nukleinsyre-overføringsmidler
TR199902434T2 (xx) Bakteriyel plazmidler.
WO1999066077A3 (en) Methods for the detection of nucleic acids
ATE449180T1 (de) Transglutaminase genprodukte